ARTICLE | Clinical News
SA4Ag: Phase IIb started
July 13, 2015 7:00 AM UTC
Pfizer began the double-blind, placebo-controlled, U.S. Phase IIb STRIVE trial to evaluate a single intramuscular dose of PF-06290510 in about 2,600 patients. Pfizer has exclusive, worldwide rights to...